CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy
Meihua Jin, Jonghwa Ahn, Yu-Mi Lee, Tae-Yon Sung, Won Gu Kim, Tae Yong Kim, Jin-Sook Ryu, Won Bae Kim, Young Kee Shong, Min Ji Jeon
Endocrinol Metab. 2020;35(3):602-609.   Published online September 22, 2020
DOI: https://doi.org/10.3803/EnM.2020.741

Excel Download

Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy
Meihua Jin, Jonghwa Ahn, Yu-Mi Lee, Tae-Yon Sung, Won Gu Kim, Tae Yong Kim, Jin-Sook Ryu, Won Bae Kim, Young Kee Shong, Min Ji Jeon
Endocrinology and Metabolism. 2020;35(3):602-609   Crossref logo
Link1 Link2 Link3
Response to Tulchinsky and Avram re: “Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine”
Muhammad Mujammami, Michael Tamilia
Thyroid. 2017;27(4):592-592   Crossref logo
Link1 Link2
Unfavorable Responses to Radioiodine Therapy in N1b Papillary Thyroid Cancer: A Propensity Score Matching Study
Yan-Qing Liu, Hui Li, Jie-Rui Liu, Yan-Song Lin
Endocrine Practice. 2019;25(12):1286-1294   Crossref logo
Link1 Link2
Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 milliCuries Radioiodine
Muhammad Mujammami, Michael P. Hier, Richard J. Payne, Louise Rochon, Michael Tamilia
Thyroid. 2016;26(7):951-958   Crossref logo
Link1 Link2
Clinical outcomes of patients with T4 or N1b well-differentiated thyroid cancer after different strategies of adjuvant radioiodine therapy
Shin Young Jeong, Sang-Woo Lee, Wan Wook Kim, Jin Hyang Jung, Won Kee Lee, Byeong-Cheol Ahn, Jaetae Lee
Scientific Reports. 2019;9(1):   Crossref logo
Link1 Link2 Link3
Re: “Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine” by Mujammami et al. (Thyroid 2016;26:951–958): Patient Cohort Definition Makes No Sense
Mark Tulchinsky, Anca M. Avram
Thyroid. 2017;27(4):591-591   Crossref logo
Link1 Link2
Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases
Christine J. O'Neill, Nicholas Coorough, James C. Lee, Joshua Clements, Leigh W. Delbridge, Rebecca Sippel, Mark S. Sywak, Herb Chen, Stan B. Sidhu
ANZ Journal of Surgery. 2013;84(4):240-244   Crossref logo
Link1 Link2
Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer
Jérôme-Philippe Garsi, Martin Schlumberger, Marcel Ricard, Martine Labbé, Claudia Ceccarelli, Claire Schvartz, Michel Henry-Amar, Stéphane Bardet, Carole Rubino, Florent De Vathaire
Clinical Endocrinology. 2009;71(6):880-883   Crossref logo
Link1 Link2
Radioiodine Ablation for Differentiated Thyroid Cancer—None, One Dose or Two?
G.J.G. Rees
Clinical Oncology. 2010;22(2):131-135   Crossref logo
Link1 Link2
Re-audit of Selection of Thyroid Cancer Patients for Therapeutic Doses of Radioiodine – Does Using a Cut-off of Thyroglobulin >10 after Iodine 131 Ablation Predict for the Need for Subsequent Doses of Iodine 131?
S. Aslam, R. Benson, I. Harrison, S. Jefferies
Clinical Oncology. 2011;23(3):S28-S29   Crossref logo
Link1 Link2